Experimental vaccine trial for rare adrenal cancers halted early
NCT ID NCT04187404
First seen Feb 01, 2026 · Last updated May 23, 2026 · Updated 15 times
Summary
This early-stage trial tested a new therapeutic vaccine (EO2401) combined with immune-boosting drugs in 70 people with advanced adrenal gland cancers (adrenocortical carcinoma or malignant pheochromocytoma/paraganglioma). The goal was to see if the combination was safe and could shrink tumors or slow cancer growth. The study was terminated early, so final results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHEOCHROMOCYTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Amsterdam UMC, location VUmc
Amsterdam, 1081, Netherlands
-
Assistance Publique - Hôpitaux de Marseille - Hôpital Nord
Marseille, 13915, France
-
Azienda Ospedaliera Spedali Civili
Brescia, 25121, Italy
-
Centre Léon Bérard
Lyon, 69008, France
-
Chu Lille
Lille, 59037, France
-
Hospital Universitari Vall d'Hebron
Barcelona, 08035, Spain
-
Institut Gustave Roussy
Villejuif, 94800, France
-
Karolinska University Hospital
Stockholm, 17176, Sweden
-
Lmu Klinikum
München, Germany
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Rigshospitalet
Copenhagen, 2100, Denmark
-
Universitätsklinikum Würzburg
Würzburg, 97080, Germany
Conditions
Explore the condition pages connected to this study.